Adult rats treated with risperidone during development are hyperactive

Experimental and Clinical Psychopharmacology

Volumn 21, Issue 3, 2013, Pages 259-267

  Bardgett, Mark E ^a   Franks Henry, Julie M ^a   Colemire, Kristin R ^a   Juneau, Kathleen R ^a   Stevens, Rachel M ^a   Marczinski, Cecile A ^a   Griffith, Molly S ^a  

^a NORTHERN KENTUCKY UNIVERSITY   (United States)

Author keywords

Antipsychotic drug; Dopamine; Gender; Locomotor activity; Reversal learning

Indexed keywords

ANIMALS; ANTIPSYCHOTIC AGENTS; FEMALE; HYPERKINESIS; LEARNING; MALE; RATS; RATS, LONG-EVANS; RISPERIDONE;

EID: 84882634549     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0031972     Document Type: Article

References (41)

1. Arnt, J. (1995). Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine. European Journal of Pharmacology, 283, 55- 62. doi:10.1016/0014- 2999(95)00292-S
2. Baptista, T., Araujo de Baptista, E., Ying Kin, N. M., Beaulieu, S., Walker, D., Joober, R., . . . Richard, D. (2002). Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: Bodyweight, food intake, body composition, hormones and glucose tolerance. Brain Research, 957, 144-151. doi:10.1016/S0006-8993(02)03616-8
3. Bardgett, M. E. (2004). Behavioral models of atypical antipsychotic drug action. In J. Csernansky & J. Laurello (Eds.), Atypical antipsychotics: From bench to bedside (pp. 61-93). New York, NY: Marcel Dekker.
4. Bardgett, M. E., Boeckman, R., Krochmal, D., Fernando, H., Ahrens, R., & Csernansky, J. G. (2003). NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice. Brain Research Bulletin, 60, 131-142. doi:10.1016/ S0361-9230(03)00023-6
5. Bardgett, M. E., Points, M., Kleier, J., Blankenship, M., & Griffith, M. S. (2010). The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats. Neuropharmacology, 59, 492-502. doi:10.1016/j.neuropharm.2010.07 .004
6. Bardgett, M. E., Points, M., Ramsey-Faulkner, C., Topmiller, J., Roflow, J., McDaniel, T., . . . Griffith, M. S. (2008). The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss. Neuropsychopharmacology, 33, 1980-1991. doi:10.1038/sj.npp .1301580
7. Choi, Y. K., Gardner, M. P., & Tarazi, F. I. (2009). Effects of risperidone on glutamate receptor subtypes in developing rat brain. European Neuropsychopharmacology, 19, 77-84. doi:10.1016/j.euroneuro.2008.08 .010
8. Choi, Y. K., Moran-Gates, T., Gardner, M. P., & Tarazi, F. I. (2010). Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European Neuropsychopharmacology, 20, 187-194. doi:10.1016/j.euroneuro.2009.09.002
9. Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA: Journal of the American Medical Association, 302, 1765- 1773. doi:10.1001/jama.2009.1549
10. Cuomo, V., Cagiano, R., Coen, E., Mocchetti, I., Cattabeni, F., & Racagni, G. (1981). Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol. Psychopharmacology, 74, 166-169. doi:10.1007/BF00432686
11. Cuomo, V., Cagiano, R., Mocchetti, I., Coen, E., Cattabeni, F., & Racagni, G. (1983). Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine. Psychopharmacology, 81, 239-243. doi:10.1007/BF00427270
12. Curtis, L. H., Masselink, L. E., Østbye, T., Hutchison, S., Dans, P. E., Wright, A., . . . Schulman, K. A. (2005). Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States. Archives of Pediatric & Adolescent Medicine, 159, 362-366. doi:10.1001/archpedi.159.4.362
13. Domino, M. E., & Swartz, M. S. (2008). Who are the new users of antipsychotic medications?. Psychiatric Services, 59, 507-514. doi: 10.1176/appi.ps.59.5.507
14. Evans, S. M. (2007). The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Experimental and Clinical Psychopharmacology, 15, 418-426. doi:10.1037/1064-1297.15.5 .418
15. Evans, S. M., & Foltin, R. W. (2010). Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates?. Hormones and Behavior, 58, 13-21. doi:10.1016/j.yhbeh .2009.08.010
16. Fanton, J., & Gleason, M. M. (2009). Psychopharmacology and preschoolers: A critical review of current conditions. Child and Adolescent Psychiatric Clinics of North America, 18, 753-771. doi:10.1016/j.chc.2009 .02.005
17. Haluk, D. M., & Floresco, S. B. (2009). Ventral striatal dopamine modulation of different forms of behavioral flexibility. Neuropsychopharmacology, 34, 2041-2052. doi:10.1038/npp.2009.21
18. Kalverdijk, L. J., Tobi, H., van den Berg, P. B., Buiskool, J., Wagenaar, L., Minderaa, R. B., & de Jong-van den Berg, L. T. (2008). Use of antipsychotic drugs among Dutch youths between 1997 and 2005. Psychiatric Services, 59, 554-560. doi:10.1176/appi.ps.59.5.554
19. Kapur, S., VanderSpek, S. C., Brownlee, B. A., & Nobrega, J. N. (2003). Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: A suggested solution based on in vivo occupancy. The Journal of Pharmacology and Experimental Therapeutics, 305, 625-631. doi:10.1124/jpet.102.046987
20. Kuehn, B. M. (2009). FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse. JAMA: Journal of the American Medical Association, 302, 833-834. doi:10.1001/jama.2009.1152
21. Llorente-Berzal, A., Mela, V., Borcel, E., Valero, M., López-Gallardo, M., Viveros, M. P., & Marco, E. M. (2012). Neurobehavioral and metabolic long-term consequences of neonatal maternal deprivation stress and adolescent olanzapine treatment in male and female rats. Neuropharmacology, 62, 1332-1341. doi:10.1016/j.neuropharm.2011.07.031
22. Mandell, D. J., Unis, A., & Sackett, G. P. (2011). Post-drug consequences of chronic atypical antipsychotic drug administration on the ability to adjust behavior based on feedback in young monkeys. Psychopharmacology, 215, 345-352. doi:10.1007/s00213-010-2147-6
23. Moran-Gates, T., Grady, C., Shik Park, Y., Baldessarini, R. J., & Tarazi, F. I. (2007). Effects of risperidone on dopamine receptor subtypes in developing rat brain. European Neuropsychopharmacology, 17, 448- 455. doi:10.1016/j.euroneuro.2006.10.004
24. Muller, P., & Seeman, P. (1978). Dopaminergic supersensitivity after neuroleptics: Time-course and specificity. Psychopharmacology, 60, 1-11. doi:10.1007/BF00429171
25. National Research Council. (2011). Guide for the care and use of laboratory animals (8th ed.). Washington, DC: The National Academies Press.
26. Pandina, G. J., Bilder, R., Harvey, P. D., Keefe, R. S., Aman, M. G., & Gharabawi, G. (2007). Risperidone and cognitive function in children with disruptive behavior disorders. Biological Psychiatry, 62, 226-234. doi:10.1016/j.biopsych.2006.09.036
27. Pandina, G. J., Zhu, Y., & Cornblatt, B. (2009). Cognitive function with long-term risperidone in children and adolescents with disruptive behavior disorder. Journal of Child and Adolescent Psychopharmacology, 19, 749-756. doi:10.1089/cap.2008.0159
28. Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., & Jensen, P. S. (2005). Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 548-556. doi:10.1097/01.chi.0000157543.74509.c8
29. Rosengarten, H., & Friedhoff, A. J. (1979). Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science, 203, 1133-1135. doi:10.1126/science.570724
30. Sackett, G., Unis, A., & Crouthamel, B. (2010). Some effects of risperidone and quetiapine on growth parameters and hormone levels in young pigtail macaques. Journal of Child and Adolescent Psychopharmacology, 20, 489-493. doi:10.1089/cap.2010.0018
31. Samaha, A. N., Reckless, G. E., Seeman, P., Diwan, M., Nobrega, J. N., & Kapur, S. (2008). Less is more: Antipsychotic drug effects are greater with transient rather than continuous delivery. Biological Psychiatry, 64, 145-152. doi:10.1016/j.biopsych.2008.01.010
32. Scalzo, F. M., & Spear, L. P. (1985). Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats. Psychopharmacology, 85, 271-276. doi:10.1007/BF00428186
33. Shalaby, I. A., & Spear, L. P. (1980). Chronic administration of haloperidol during development: Later psychopharmacological responses to apomorphine and arecoline. Pharmacology, Biochemistry, & Behavior, 13, 685-690. doi:10.1016/0091-3057(80)90012-X
34. Soiza-Reilly, M., & Azcurra, J. M. (2009). Developmental striatal critical period of activity-dependent plasticity is also a window of susceptibility for haloperidol induced adult motor alterations. Neurotoxicology and Teratology, 31, 191-197. doi:10.1016/j.ntt.2009.03.001
35. Spear, L. P. (2000). The adolescent brain and age-related behavioral manifestations. Neuroscience and Biobehavioral Reviews, 24, 417-463. doi:10.1016/S0149-7634(00)00014-2
36. van der Meulen, J. A., Joosten, R. N., de Bruin, J. P., & Feenstra, M. G. (2006). Dopamine and noradrenaline efflux in the medial prefrontal cortex during serial reversals and extinction of instrumental goaldirected behavior. Cerebral Cortex, 17, 1444-1453. doi:10.1093/cercor/ bhl057
37. Velley, L., Blanc, G., Tassin, J. P., Thierry, A. M., & Glowinski, J. (1975). Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life. Naunyn Schmiedeberg's Archives of Pharmacology, 288, 97-102. doi:10.1007/BF00501817
38. Wiley, J. L. (2008). Antipsychotic-induced suppression of locomotion in juvenile, adolescent and adult rats. European Journal of Pharmacology, 578, 216-221. doi:10.1016/j.ejphar.2007.09.010
39. Wiley, J. L., & Evans, R. L. (2008). Evaluation of age and sex differences in locomotion and catalepsy during repeated administration of haloperidol and clozapine in adolescent and adult rats. Pharmacological Research, 58, 240-246. doi:10.1016/j.phrs.2008.08.002
40. Wiley, J. L., & Evans, R. L. (2009). To breed or not to breed? Empirical evaluation of drug effects in adolescent rats. International Journal of Developmental Neuroscience, 27, 9-20. doi:10.1016/j.ijdevneu.2008.11 .002
41. Zuo, J., Liu, Z., Ouyang, X., Liu, H., Hao, Y., Xu, L., & Lu, X. H. (2008). Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats. Progress in Neuro- Psychopharmacology & Biological Psychiatry, 32, 387-397. doi: 10.1016/j.pnpbp.2007.09.005